1. Home
  2. List
Reference Patent

Reference - List

  • 43 Hits
  • Search Condition : Filter (MeSH = Mouth Neoplasms / genetics*)
Species Resource Title
Human and Animal Cells Saos-2(RCB0428) Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells.
Human and Animal Cells HSC-4(RCB1902) , HO-1-u-1(RCB2102) , SAS(RCB1974) , Sa3(RCB0980) , Ca9-22(RCB1976) , HSC-3(RCB1975) , HSC-2(RCB1945) Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , Ca9-22(RCB1976) PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Ca9-22(RCB1976) , Kato III(RCB2088) , CW-2(RCB0778) , COLO-320(RCB1193) Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells.
Human and Animal Cells SAS(RCB1974) Decreased prostasin expression is associated with aggressiveness of oral squamous cell carcinoma.
Human and Animal Cells SAS(RCB1974) Hyaluronan synthase 3 mediated oncogenic action through forming inter-regulation loop with tumor necrosis factor alpha in oral cancer.
Human and Animal Cells HSC-3(RCB1975) AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression.
Human and Animal Cells SAS(RCB1974) BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Human and Animal Cells Ca9-22(RCB1976) , HSC-2(RCB1945) , HSC-4(RCB1902) , Sa3(RCB0980) , HSQ-89(RCB0789) , SAS(RCB1974) , HO-1-u-1(RCB2102) Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.
Human and Animal Cells T3M-1 Clone2(RCB1015) , T3M-1 Cl-10(RCB1017) , CJM(RCB1034) Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
Human and Animal Cells T3M-1 Clone2(RCB1015) , T3M-1 Cl-10(RCB1017) , HSC-3(RCB1975) , HSC-2(RCB1945) , HSC-4(RCB1902) Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.
Human and Animal Cells MRC-5 Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Sa3(RCB0980) , Ca9-22(RCB1976) , HO-1-u-1(RCB2102) , SAS(RCB1974) Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma.
Human and Animal Cells A431 , Ca9-22(RCB1976) Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1).
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Ca9-22(RCB1976) , Sa3(RCB0980) , HO-1-u-1(RCB2102) Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review.
Human and Animal Cells HSC-4(RCB1902) Determination of the origin of oral squamous cell carcinoma by microarray analysis: Squamous epithelium or minor salivary gland?
Human and Animal Cells HSC-3(RCB1975) , HSC-2(RCB1945) Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Sa3(RCB0980) , Ca9-22(RCB1976) , SAS(RCB1974) , Ho-1-u-1(RCB2102) , HSQ-89(RCB0789) Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
Human and Animal Cells Ca9-22(RCB1976) , HO-1-u-1(RCB2102) , SAS(RCB1974) Multiple coagulation factor deficiency protein 2 as a crucial component in metastasis of human oral cancer.
Human and Animal Cells Ca9-22(RCB1976) , HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Sa3(RCB0980) , SAS(RCB1974) TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.